186 related articles for article (PubMed ID: 1307152)
1. [The efficacy of preparations with antioxidant action in the combined treatment of phlegmons of the maxillofacial area].
Ragimov ChR
Stomatologiia (Mosk); 1992; (3-6):35-7. PubMed ID: 1307152
[TBL] [Abstract][Full Text] [Related]
2. [Use of a chloracetophos ointment in the combined treatment of acute odontogenic inflammatory processes of the maxillofacial area].
Khamitov FS; Faizov TT; Berim MG
Stomatologiia (Mosk); 1985; 64(1):35-7. PubMed ID: 3857735
[No Abstract] [Full Text] [Related]
3. [The optimization of the regeneration of a suppurative wound in the maxillofacial area by using lymphogenic therapy].
Shumskiĭ AV; Pozdniĭ AIu; Morozov PV
Voen Med Zh; 1999 May; 320(5):28-33. PubMed ID: 10401246
[No Abstract] [Full Text] [Related]
4. [Treatment of patients with phlegmon of the maxillofacial area using a levomecol ointment].
Chernoglazova EM
Stomatologiia (Mosk); 1987; 66(5):42-4. PubMed ID: 3480633
[No Abstract] [Full Text] [Related]
5. [Tactivin in the combined treatment of acute inflammatory diseases of the maxillofacial area].
Bazhanov NN; Arion VIa; Sysoeva OP; Krugliakova EP
Stomatologiia (Mosk); 1996; 75(2):31-3. PubMed ID: 8754536
[TBL] [Abstract][Full Text] [Related]
6. [New antimicrobial preparations in the overall treatment of suppurative inflammatory processes in the maxillofacial area].
Solomennyĭ SM; Paliĭ GK; Burdeniuk IP
Stomatologiia (Mosk); 1979; 58(2):39-41. PubMed ID: 375477
[No Abstract] [Full Text] [Related]
7. [The use of the preparation baliz-2 in inflammatory processes of the maxillofacial area].
Bernadskaia GP; Timofeev AA; Kutsenko TA
Stomatologiia (Mosk); 1989; 68(6):10-1. PubMed ID: 2623675
[TBL] [Abstract][Full Text] [Related]
8. [The use of netromycin in suppurative maxillofacial surgery in children].
Roginskiĭ VV; Gerchikov LN; Raĭlian SK; Beliaeva EI; Pavelko GA
Stomatologiia (Mosk); 1994; 73(3):68-71. PubMed ID: 7846723
[No Abstract] [Full Text] [Related]
9. [Clinical and experimental bases for using dibasol in inflammatory diseases of the maxillofacial area].
Alekhova TM
Stomatologiia (Mosk); 1982; 61(1):15-7. PubMed ID: 6950550
[No Abstract] [Full Text] [Related]
10. [The therapy of inflammatory diseases of the maxillofacial area with the use of imidazole derivatives].
Ushakov RV; Tsarev VN; Dugarov BD; Lopyrev VA
Stomatologiia (Mosk); 1992; (3-6):31-4. PubMed ID: 1307150
[TBL] [Abstract][Full Text] [Related]
11. [Action of UV irradiation on wound healing after incising maxillofacial phlegmons].
Nanuev SI; Zausaev VI; Kats AG; Malomud ZP
Stomatologiia (Mosk); 1984; 63(5):43-5. PubMed ID: 6593917
[No Abstract] [Full Text] [Related]
12. [The antioxidant correction of lipid peroxidation in maxillofacial phlegmons].
Gavriliuk LA; Lungu SE; Shcherbatiuk DI
Stomatologiia (Mosk); 1994; 73(2):33-5. PubMed ID: 9612045
[No Abstract] [Full Text] [Related]
13. [Indications for the use of tactivin in the combined treatment of phlegmons of the maxillofacial area].
Drobyshev VIu; Volozhin AI; Agapov VS; Sashkina TI
Stomatologiia (Mosk); 1996; 75(4):27-30. PubMed ID: 8992659
[TBL] [Abstract][Full Text] [Related]
14. [Clinical results of perftorane use in comprehensive treatment of patients with odontogenic phlegmons].
Durnovo EA; Furman IV
Stomatologiia (Mosk); 2007; 86(4):35-9. PubMed ID: 17828096
[TBL] [Abstract][Full Text] [Related]
15. [The clinico-laboratory assessment of the efficacy of dalargin in treating acute suppurative-inflammatory processes of the maxillofacial area].
Bazhanov NN; Ganina SS; Pashutin SB; Ragimov ChR
Sov Med; 1991; (7):29-31. PubMed ID: 1948337
[TBL] [Abstract][Full Text] [Related]
16. [Neutrophil-macrophage correlations during the healing of suppurative wounds in patients with phlegmons of the maxillofacial area undergoing combined treatment with the use of low-frequency ultrasound].
Mukhsinov ME; Bazhanov NN; Pol'skiĭ VI
Stomatologiia (Mosk); 1989; 68(5):45-9. PubMed ID: 2588280
[TBL] [Abstract][Full Text] [Related]
17. [Ways to improve the treatment of patients with phlegmons of the maxillofacial area].
Bazhanov NN; Shcherbatiuk DI
Stomatologiia (Mosk); 1992; (1):34-6. PubMed ID: 1440671
[TBL] [Abstract][Full Text] [Related]
18. [Means of decreasing complications in patients with severe inflammatory diseases of the maxillofacial area].
Zakharova GN; Bulkin VA
Stomatologiia (Mosk); 1987; 66(3):37-9. PubMed ID: 3475830
[No Abstract] [Full Text] [Related]
19. [The efficacy of using a helium-neon laser, ascorbic acid and methylene blue in the combined treatment of patients with maxillofacial phlegmons].
Bazhanov NN; Ragimov ChR; Kasymov AI
Stomatologiia (Mosk); 1990; (5):35-7. PubMed ID: 2281486
[TBL] [Abstract][Full Text] [Related]
20. [The intestinal microflora of patients with inflammatory diseases of the maxillofacial area].
Bevz NI; Budanova EV; Pashkov EP; Ter-Asaturov GP; Goncharova GI
Zh Mikrobiol Epidemiol Immunobiol; 1994; (4):22-4. PubMed ID: 7992527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
